A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines
Clinical trial NCT05434585 · UNKNOWN
Trial details
- NCT number
- NCT05434585
- Sponsor
- Suzhou Abogen Biosciences Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-08
- Primary completion
- 2022-10-10
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.